Evaluation of two year treatment outcome and limited impact of arginine restriction in a patient with GAMT deficiency.
Mercimek-Mahmutoglu S, Dunbar M, Friesen A, Garret S, Hartnett C, Huh L, Sinclair G, Stockler S, Wellington S, Pouwels PJ, Salomons GS, Jakobs C.
Mercimek-Mahmutoglu S, et al. Among authors: hartnett c.
Mol Genet Metab. 2012 Jan;105(1):155-8. doi: 10.1016/j.ymgme.2011.09.037. Epub 2011 Oct 6.
Mol Genet Metab. 2012.
PMID: 22019491